Current Neuro-Oncology
Volume
28 Number 15
31 May 2026
Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 15, 31 May
Jung IH, Yoo J, Choi S, Roh TH, Park HH, Lim J, Moon JH, Kim EH,
Kang SG, Kim SH, Chang JH.
Survival
analysis of adult
midline-located gliomas and diffuse midline gliomas: beyond the
H3K27 mutation paradigm.
J
Neurooncol. 2026 May 22;178(1):17. doi:
10.1007/s11060-026-05625-0. PMID:
42174302˰ ˍ
Mathews N, Jaffe A, McMichael K, Redjal N, Cardonick EH, Swanson
TA, Kry SF, Salacz ME, Mann JM.
Magnetic
Resonance Guided Radiation Therapy for High-Grade Glioma in
Pregnancy: Planning, Validation, and Adaptive Fetal Dose
Monitoring.
Adv
Radiat Oncol. 2026 May 22;11(10):102099. doi:
10.1016/j.adro.2026.102099. PMID:
42382437. ˍ
Pillai LK, Mehta MJ, Parikh A, Dash N, Shivhare V, Shah SP, Pandya
A, Singh JK, Prajapati K, Bahuguna A, Darji R.
Assessment
of subventricular zone irradiation in glioblastoma patients.
Front
Oncol. 2026 May 22;16:1818058. doi:
10.3389/fonc.2026.1818058. PMID:
42255216. ˍ
Rudra Gupta T, Polley MC, Redd R, Lee EQ, Arrillaga-Romany I,
Gilbert MR, Tan Y, Touat M, Drappatz J, Welch MR, Galanis E,
Ahluwalia MS, Colman H, Nabors LB, Hepel J, Elinzano H, Schiff D,
Chukwueke UN, Beroukhim R, Nayak L, McFaline-Figueroa JR,
Batchelor TT, Kaley TJ, Lu-Emerson C, Mellinghoff IK, Bi WL,
Arnaout O, Peruzzi PP, Haas-Kogan D, Tanguturi S, Aizer A, Doherty
L, Santagata S, Meredith DM, Chiocca EA, Reardon DA, Ligon KL,
Weller M, Mehta MP, Wen PY, Trippa L, Rahman R.
Treatment
Effect Reanalysis of the Randomized Individual Screening Trial of
Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma
With External Control Data.
J
Clin Oncol. 2026 May 22:JCO2501586. doi:
10.1200/JCO-25-01586. PMID:
42172567. Trial
registration ID: NCT02977780˰
ˍ
Chun SJ, Kim N, Lim DH, Kim JY, Wee CW, Yoon HI, Jeon SH, Kim IA,
Lee JH.
Impact of salvage treatment
for recurrent medulloblastoma in previously irradiated patients
(KROG 23-02): A multi-institutional retrospective study.
Clin
Transl Radiat Oncol. 2026 May 26;59:101197. doi:
10.1016/j.ctro.2026.101197. PMID:
42255978. ˍ
Lukas RV, Zhai L, Lauing KL, Kim M, Koch T, Penco-Campillo M,
Bommi P, Dixit K, Kumthekar P, Sharp L, Lezon R, Garcia D,
Sonabend AM, McCortney K, Castro BA, Chandler JP, Gondi V, Grimm
SA, Miska JM, Heimberger AB, Dobinda K, Zhang H, Sachdev S, Juhasz
C, James CD, Allen JM, Horbinski C, Lesniak MS, Stupp R,
Wainwright DA.
Phase 1 evaluation of
patients with newly diagnosed glioblastoma treated with radiation,
nivolumab, and IDO1 enzyme inhibitor BMS-986205.
Clin
Cancer Res. 2026 May 26. doi:
10.1158/1078-0432.CCR-26-1124. PMID:
42189896. Trial
registration ID: NCT04047706.
ˍ
Arumugam
A, Meira Castro Trindade R, Hendricks A, Powell MR, Bansal J.
Brain
Metastasis Occurring a Decade After Prostate Cancer Diagnosis: A
Case Report.
Cureus.
2026 May 27;18(5):e109715. doi:
10.7759/cureus.109715. PMID:
42367519. ˍ
Ghaedian T, Aghaei H, Rakhsha A, Ghaedian M, Alipour A, Shariat S,
Shabani Z, Eghbal K, Jamali M, Rahmanian A, Mohammadhosseini E,
Ashrafi Z, Davlatov M.
Diagnostic
accuracy of [99mTc]-Tc-HYNIC-PSMA-11
SPECT/CT in differentiating tumor recurrence from post-treatment
changes in glioblastoma.
Neuroradiology.
2026 May 28. doi:
10.1007/s00234-026-04042-4. PMID:
42207247˰ ˍ
Zabor EC.
Propensity Score-Matched
External Controls in Rare Disease Trials: A Promising Tool
Requiring Rigorous Validation.
J
Clin Oncol. 2026 May 28:JCO2600816. doi:
10.1200/JCO-26-00816. PMID:
42208047. ˍ
Ellingson BM, Cloughesy TF, Ye X, Teraishi A, Raymond C, Oshima S,
Sanvito F, Wen PY, Walbert T, Campian JL, Nabors LB, Ozer BH,
Desai A, Omuro A, Desideri S, Danda N, Grossman SA, Bindra RS,
Schiff D.
Tumor Growth Rate (TGR)
Analysis Predicts Survival in a Multicenter Phase II Study of the
PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent
IDH-Mutant Gliomas (ABTC-1801).
AJNR
Am J Neuroradiol. 2026 May 29:ajnr.A9438. doi:
10.3174/ajnr.A9438. PMID:
42217836. Trial
registrationID: NCT03914742˰
ˍ
Salahi Ardekani O, Zarezade M, Meymandi B, Azami N, Mahdavi B,
Shahani T.
Recent advances in
oncolytic virotherapy: insights from clinical trials and
combination treatment strategies.
Virol
J. 2026 May 29. doi:
10.1186/s12985-026-03207-0. PMID:
42216079. ˍ
Skeie BS, Craig-Craven AR, Grüner ER, Biermann M, Riemer F,
Bragstad S, Sarowar S, Behbahani M, Sleire L, Schwarzlmüller
T, Goplen D, Heggdal JI, Knisely JPS, Schulder M, Eide GE, Filippi
CG, Enger PØ.
Phase 1
dose-escalation trial combining sulfasalazine and stereotactic
radiosurgery in patients with recurrent glioblastoma.
Redox
Biol. 2026 May 30;95:104241. doi:
10.1016/j.redox.2026.104241. PMID:
42229231. Trial
registration ID: NCT04205357. ˍ
Wang D, Liu X, Wang J, Zhang B, Zhai S, Xu J, Wang L, Zheng Y, Wei
W, Zhou Y.
Efficacy of
chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic
pontine glioma: a study based on single-center and SEER data.
J
Neurooncol. 2026 May 30;178(1):36. doi:
10.1007/s11060-026-05622-3. PMID:
42218248. ˍ